Document ID: chunk:federal_register_of_legislation:F2020C00810:reg:4
Version: federal_register_of_legislation:F2020C00810
Segment Type: reg
Provision Reference: reg 4
Character Range: 8296–9875

4  Formulation information
 (1) The following information is the formulation information in relation to a chemical product:
 (a) for each active or other constituent in relation to the chemical product:
  (i) the name of the constituent; and
  (ii) the CAS number of the constituent; and
  (iii) the applicable constituent standard (if any); and
  (iv) the concentration of the constituent; and
  (v) the purpose of the constituent in the formulation of the product;
 (b) the total weight or volume of the product (as applicable);
 (c) if the product is a liquid –the specific gravity of the product;
 (d) the formulation type of the product;
 (e) whether the product contains any ingredients that have a risk of transmitting agents of animal spongiform encephalopathies;
 (f) whether the product contains any genetically modified organism or any product derived from a genetically modified organism;
 (g) whether the product contains any ingredients intentionally engineered to be less than 100 nanometres in one or more dimensions and, if so, those ingredients.
 (2) Where this Instrument requires an application to contain, or be accompanied by, formulation information:
 (a) the information need not be provided by the applicant (for example, it may be provided by a manufacturer of the product); and
 (b) the person providing the information must state the persons, if any, to whom the information may be disclosed; and
 (c) the information must be accompanied by a declaration, signed by the person providing the information, that the information is complete and correct.